Xiamen University
Also known as: Clinical Trial Center of Xiamen Cardiovascular Hospital | First affiliated Hospital of Xiamen University | Fujian Children's Hospital | Fuzhou General Hospital, Xiamen Univ | National Institute of Diagnostics and Vaccine Development in infectious disease | National Institute of Diagnostics and Vaccine Development in infectious disease, Xiamen University | Southeast Hospital affiliated to Xiamen University | The First Affiliated Hospital of Xiamen University | The First Affiliated Hospital of Xiamen University, China | The First Affiliated of Xiamen University | The first afilliated hospital of Xiamen university | The First Aiffiliated hosptical of xiamen University | Xiamen Cardiovascular Hospital, Xiamen University | Xiamen Chang gung hospital | Xiamen Children's Hospital | Xiamen Children's Hospital, Fujian of China | Xiamen Eye Center Affiliated to Xiamen University | Xiamen Eye Center of Xiamen University | Xiamen Hospital of Traditional Chinese Medicine | Xiamen Ophthalmology Center Affiliated to Xiamen University | Xiamen traditional Chinese medicine hospital | Xiamen University | Xiamen University Malaysia | Xiamen University Zhongshan Hospital | Xiang'an Hospital of Xiamen University | Zhang Ying Qian | ZhiYong Peng | Zhongnan Hospital | Zhongshan boai Hospital | Zhongshan Hospital affiliated to Fu Dan University | Zhongshan Hospital Affiliated to Xiamen University | Zhongshan Hospital Of Traditional Chinese Medicine | Zhongshan Hospital, Shanghai | Zhongshan Hospital, Shanghai, China | Zhongshan Hospital Xiamen University | Zhongshan Ophthalmic center, Sun Yat-sen University | Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China | Zhongshan People's Hospital | Zhongshan People's Hospital, Guangdong, China | Zhongshan University Affliated Cancer Hospital
Highest phase reached
Phase 4
First clinical trial
Aug 1, 2007Last known activity
Jan 1, 2026
Timeline
1920s
- Jun 1, 1921
Xiamen University— Founded
Drugs by trial phase (223 distinct, 230 trials)
Phase 4 (48 own, 0 via acquisition)
Phase 3 (60 own, 0 via acquisition)
Phase 2 (71 own, 0 via acquisition)
Phase 1 (16 own, 0 via acquisition)
Other trials (28 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Adenocarcinoma
- Adenoviridae Infections
- Albuminuria
- Angina, Unstable
- beta-Thalassemia
- Brain Diseases
- Breast Neoplasms
- Bronchopulmonary Dysplasia
- Burns
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Cerebral Infarction
- Cervical Intraepithelial Neoplasia
- Colitis
- Colitis, Ulcerative
- Colonic Neoplasms
- Colorectal Neoplasms
- Constipation
- Diabetes Mellitus
- Diabetes Mellitus, Type 2
- Diabetic Nephropathies
- Diarrhea
- Dry Eye Syndromes
- Dwarfism, Pituitary
- Endocrine System Diseases
- Esophageal Squamous Cell Carcinoma
- Eye Burns
- Glaucoma
- Glaucoma, Open-Angle
- Graft vs Host Disease
- Graves Ophthalmopathy
- Hematologic Diseases
- Hepatitis
- Hepatitis A
- Hepatitis E
- Hepatoblastoma
- Hyperglycemia
- Hyperparathyroidism
- Hyperparathyroidism, Secondary
- Hypertension
- Infections
- Inflammatory Bowel Diseases
- Intestinal Diseases
- Intracranial Arteriosclerosis
- Intracranial Embolism
- Intracranial Thrombosis
- Irritable Bowel Syndrome
- Ischemia
- Keratoconjunctivitis Sicca
- Kidney Diseases
- Leukemia
- Leukemia, Lymphoid
- Leukemia, Myeloid
- Leukemia, Myeloid, Acute
- Liver Neoplasms
- Lung Neoplasms
- Malnutrition
- Nasopharyngeal Carcinoma
- Nasopharyngeal Neoplasms
- Neointima
- Neoplasm Metastasis
- Neoplasms
- Neuroblastoma
- Ocular Hypertension
- Ovarian Neoplasms
- Overweight
- Peritoneal Neoplasms
- Pneumonia
- Pneumonia, Ventilator-Associated
- Pneumonia, Viral
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Premature Birth
- Purpura, Thrombocytopenic, Idiopathic
- Retinoblastoma
- Seizures
- Sepsis
- Stomach Neoplasms
- Stroke
- Syndrome
- Thalassemia
- Thrombocytopenia
- Thrombosis
- Toxemia
- Ulcer
- Uterine Cervical Neoplasms
Recent trials (50)
- NCT07288749CollaboratorPhase 3Jan 1, 2026
- NCT07291401Lead sponsorPhase 2Jan 1, 2026
- NCT07296614CollaboratorPhase 3Dec 25, 2025
- NCT07239674CollaboratorPhase 3Nov 30, 2025
- NCT07240376Sponsor investigatorN/ANov 25, 2025
- NCT07240376OfficialN/ANov 25, 2025
- NCT07132008CollaboratorPhase 3Oct 1, 2025
- NCT07196657CollaboratorN/ASep 30, 2025
- NCT07181499OfficialPhase 2Sep 30, 2025
- NCT07189884Lead sponsorPhase 1/Phase 2Sep 23, 2025
- NCT07177794CollaboratorPhase 3Sep 20, 2025
- NCT07165158Lead sponsorPhase 4Sep 15, 2025
- NCT06902740CollaboratorPhase 4Sep 1, 2025
- NCT07137039Lead sponsorPhase 2Aug 20, 2025
- NCT07137039Sponsor investigatorPhase 2Aug 20, 2025
Details
- Founded
- Xiamen, CN Jun 1, 1921
- Last known activity
- Jan 1, 2026